Boehringer Ingelheim Rhinomune (EHV-1) Equine Vaccine 25 x 1 Dose

Primary infection with EHV-1 causes an acute respiratory disease characterized by nasal discharge, coughing, labored breathing, fever, slight loss of appetite, and depression. Annual outbreaks may occur among foals in areas with a large equine population. Clinical signs, occasionally persisting as long as 7 days, are generally more severe in young horses, and may be exacerbated by strenuous activity. Subclinical reinfection may also occur, with latent carriers the probable reservoir of EHV-1.

Aseptically rehydrate the freeze-dried vaccine with the sterile diluent provided. Shake well. Administer 1 mL intramuscularly. Use entire contents when first opened.

Primary Vaccination: Healthy horses 3 months of age or older should receive 2 doses administered 3-4 weeks apart. Foals should be vaccinated when maternal antibodies have declined, generally at 3 months of age. If vaccinated earlier, foals should receive the 2-dose series after reaching 3 months of age. Pregnant mares should be vaccinated after the second month of pregnancy.

Revaccination: Revaccination every 3 months with a single dose is recommended.